SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
小丁
Lv4
418 积分
2022-10-06 加入
最近求助
最近应助
互助留言
Diagnostic accuracy of Aspergillus‐specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta‐analysis
1天前
待确认
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study
21天前
已完结
Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae
21天前
已完结
Fever of unknown origin
1个月前
已完结
Antibiotic prophylaxis in trauma: GAIS, SIS-E, WSIS, AAST, WSES guidelines
1个月前
已完结
Rates of resistance to ceftazidime-avibactam and ceftolozane-tazobactam among patients treated for multidrug-resistant Pseudomonas aeruginosa bacteremia or pneumonia
2个月前
已完结
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
2个月前
已完结
Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia
2个月前
已完结
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between 2016 and 2019 in China
2个月前
已完结
Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
2个月前
已完结
没有进行任何应助
时间错误【积分已退回】
1年前
年度不对
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论